GlassScriptPhysician profile
Blake Maxwell Hampton
NPI 1831682962
$3,291.25
in general payments reported to CMS, 2019-2025
18 companies · $1,369 in 2025
The $1,369 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.99 · 2021: $84.32 · 2022: $106 · 2023: $636 · 2024: $996 · 2025: $1,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,000.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,035.59 | 2023-2025 | |
| Notal Vision, INC. | $677.02 | 2024-2025 | Foresee Home |
| Alcon Vision LLC | $532.38 | 2021-2025 | Clareon, Lensx, Eysuvis |
| Mallinckrodt Hospital Products INC. | $190.25 | 2023-2025 | Acthar |
| Abbvie INC. | $148.58 | 2023-2025 | |
| Tarsus Pharmaceuticals, INC. | $117.63 | 2024-2025 | Xdemvy |
| Allergan, INC. | $99.99 | 2019 | |
| Oyster Point Pharma, INC. | $91.95 | 2023-2024 | Tyrvaya |
| Bausch & Lomb Americas INC. | $90.25 | 2023-2025 | Envista Mx60 Iol, Envista Envy Iol, Vyzulta |
| Rxsight INC | $83.56 | 2023-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Sun Pharmaceutical Industries INC. | $52.59 | 2024-2025 | |
| Dompe US, INC. | $48.71 | 2024-2025 | Oxervate |
| Rayner Intraocular Lenses Limited | $31.82 | 2024 | Rayone Spheric, Rayner Cataract Set 1, Rayone Aspheric |
| Coherus Oncology, INC. | $26.20 | 2023 | |
| Amgen INC. | $17.72 | 2025 | Tepezza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $16.60 | 2024 | Iyuzeh |
| Harrow Eye, LLC | $16.36 | 2025 | Vevye |
| Tearlab Corp | $14.05 | 2024 | Scoutpro Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Hampton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.